Timeisbrain
A medical device for improving the diagnostics and prognostics of acute ischaemic stroke.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
* | €2.5m | Grant | |
| Total Funding | 000k | ||
| EUR | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Notes (0)
More about Timeisbrain
EditMade with AI
Developer of a biomedical device designed to automatically record and analyze neuronal electrical activity. The company specializes in optimizing the current clinical algorithm for acute ischemic stroke, enabling the medical staff to adjust therapeutic decisions for each patient, before and after admission
Keywords: Pharmaceuticals and Biotechnology, Ais Therapy, Brain Stroke Treatment, Ischemic Stroke Therapy Technology, Mechanical Thrombectomy Technology, Medical Device-Based Treatment, Prognosis Testing Application, Real Time Brain Viability.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads